Traxar T 1.125

Traxar-T 1.125 is a combination antibiotic formulated with Ceftriaxone and Tazobactam, providing broad-spectrum bacterial coverage for treating severe infections in the lungs, urinary tract, skin, bones, and abdomen. Ceftriaxone, a third-generation cephalosporin, disrupts bacterial cell wall formation, leading to effective bacterial elimination. Tazobactam enhances its action by blocking bacterial resistance, making this combination highly effective against multi-drug resistant infections. Traxar-T 1.125 is widely used for treating pneumonia, septicemia, complicated UTIs, and post-surgical infections. It is administered intravenously or intramuscularly, ensuring rapid drug delivery and superior clinical outcomes. This powerful antibiotic combination is trusted by healthcare professionals for its high efficacy and minimal side effects. Proper dosage adjustment is essential for patients with renal impairment to ensure safe administration.